The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Analysis of prognostic factors in locally advanced and metastatic pancreatic cancer treated with gemcitabine or gemcitabine and S-1 chemotherapy using individual patient data from three randomized studies.
Yousuke Nakai
No relevant relationships to disclose
Takuji Okusaka
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Takaaki Ikari
No relevant relationships to disclose
Hiroyuki Isayama
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Junji Furuse
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Hiroshi Ishii
No relevant relationships to disclose
Shogo Imai
No relevant relationships to disclose
Shota Okamura
No relevant relationships to disclose
Chikuma Hamada
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Taiho Pharmaceutical